Francoise Dromer

Summary

Affiliation: Institut Pasteur
Country: France

Publications

  1. ncbi request reprint [Cryptococcosis]
    F Dromer
    Unité de mycologie Centre national de référence des mycoses humaines et des antifongiques Institut Pasteur 75724 Paris 15
    Rev Prat 51:738-41. 2001
  2. pmc Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study
    Francoise Dromer
    Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, CNRS URA3042, Institut Pasteur, Paris, France
    PLoS Med 4:e21. 2007
  3. pmc Molecular identification of zygomycetes from culture and experimentally infected tissues
    Patrick Schwarz
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS FRE2849, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    J Clin Microbiol 44:340-9. 2006
  4. pmc Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis
    Patrick Schwarz
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, Institut Pasteur, CNRS FRE2849, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    Antimicrob Agents Chemother 50:113-20. 2006
  5. pmc Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing
    Marie Desnos-Ollivier
    Institut Pasteur, Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA3012, 75724 Paris Cedex 15, France
    Antimicrob Agents Chemother 52:3092-8. 2008
  6. pmc Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients
    Olivier Lortholary
    Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Paris, France
    Antimicrob Agents Chemother 55:532-8. 2011
  7. pmc Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa
    Dea Garcia-Hermoso
    Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Institut Pasteur, and CNRS URA3012, 25 rue du Roux, Paris 75724 Cedex 15, France
    J Clin Microbiol 47:3862-70. 2009
  8. pmc Clonal population of flucytosine-resistant Candida tropicalis from blood cultures, Paris, France
    Marie Desnos-Ollivier
    Institut Pasteur, Paris, France
    Emerg Infect Dis 14:557-65. 2008
  9. pmc Cryptococcus neoformans capsule structure evolution in vitro and during murine infection
    Dea Garcia-Hermoso
    Unité de Mycologie Moléculaire, Institut Pasteur, Paris, France
    Infect Immun 72:3359-65. 2004
  10. ncbi request reprint [Physiopathology of meningoencephalitis caused by Cryptococcus neoformans]
    Ségolène Neuville
    Service de Maladies Infectieuses et Tropicales, Hopital Saint Louis, Paris, France
    Ann Med Interne (Paris) 153:323-8. 2002

Detail Information

Publications50

  1. ncbi request reprint [Cryptococcosis]
    F Dromer
    Unité de mycologie Centre national de référence des mycoses humaines et des antifongiques Institut Pasteur 75724 Paris 15
    Rev Prat 51:738-41. 2001
    ....
  2. pmc Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study
    Francoise Dromer
    Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, CNRS URA3042, Institut Pasteur, Paris, France
    PLoS Med 4:e21. 2007
    ....
  3. pmc Molecular identification of zygomycetes from culture and experimentally infected tissues
    Patrick Schwarz
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS FRE2849, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    J Clin Microbiol 44:340-9. 2006
    ....
  4. pmc Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis
    Patrick Schwarz
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, Institut Pasteur, CNRS FRE2849, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    Antimicrob Agents Chemother 50:113-20. 2006
    ..This study demonstrates the beneficial effect of the addition of flucytosine to amphotericin B against experimental disseminated cryptococcal infection even when the C. neoformans isolate is resistant to flucytosine...
  5. pmc Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing
    Marie Desnos-Ollivier
    Institut Pasteur, Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA3012, 75724 Paris Cedex 15, France
    Antimicrob Agents Chemother 52:3092-8. 2008
    ....
  6. pmc Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients
    Olivier Lortholary
    Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Paris, France
    Antimicrob Agents Chemother 55:532-8. 2011
    ..53; 95% CI = 1.43 to 4.48; P = 0.001) and with recent exposure to caspofungin (OR = 4.79; 95% CI = 2.47 to 9.28; P < 0.001). These findings could influence future recommendations for the management of candidemia...
  7. pmc Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa
    Dea Garcia-Hermoso
    Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Institut Pasteur, and CNRS URA3012, 25 rue du Roux, Paris 75724 Cedex 15, France
    J Clin Microbiol 47:3862-70. 2009
    ..ramosa isolates and negative for all L. corymbifera isolates. In conclusion, this study reveals that two Lichtheimia species are commonly associated with mucormycosis in humans...
  8. pmc Clonal population of flucytosine-resistant Candida tropicalis from blood cultures, Paris, France
    Marie Desnos-Ollivier
    Institut Pasteur, Paris, France
    Emerg Infect Dis 14:557-65. 2008
    ..tropicalis isolates, is widespread in the Paris area. We propose the analysis of 2 polymorphic microsatellite markers coupled with URA3 sequencing to track the clone...
  9. pmc Cryptococcus neoformans capsule structure evolution in vitro and during murine infection
    Dea Garcia-Hermoso
    Unité de Mycologie Moléculaire, Institut Pasteur, Paris, France
    Infect Immun 72:3359-65. 2004
    ..Overall, our results suggest that organ-specific selection can occur during cryptococcosis...
  10. ncbi request reprint [Physiopathology of meningoencephalitis caused by Cryptococcus neoformans]
    Ségolène Neuville
    Service de Maladies Infectieuses et Tropicales, Hopital Saint Louis, Paris, France
    Ann Med Interne (Paris) 153:323-8. 2002
    ..In other immunodepressed hosts, a granulomatous inflammation containing few yeasts is usually seen. This may reflect an altered local immunological defect against C. neoformans in AIDS patients with cryptococcosis...
  11. pmc In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates
    Patrick Schwarz
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, Institut Pasteur, 75724 Paris Cedex 15, France
    Antimicrob Agents Chemother 47:3361-4. 2003
    ..Antagonism was never observed. Killing curves showed indifferent interactions between triazoles and flucytosine and synergy between amphotericin B and flucytosine...
  12. pmc Candida spp. with acquired echinocandin resistance, France, 2004-2010
    Eric Dannaoui
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA3012, 25, rue du Dr Roux, 75724 Paris Cedex 15, France
    Emerg Infect Dis 18:86-90. 2012
    ..harboring diverse and new Fksp mutations. For 12 patients, initial isolates (low MIC, wild-type Fksp sequence) and subsequent isolates (after caspofungin treatment, high MIC, mutated Fksp) were genetically related...
  13. pmc Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France
    Elodie Blanchard
    INSERM U 657, Paris, France
    Antimicrob Agents Chemother 55:5358-61. 2011
    ..25; 95% confidence interval [95% CI], 1.68-16.35) and with an age of ≤ 65 years (OR = 3.27; 95% CI, 1.26-8.50)...
  14. pmc Debaryomyces hansenii (Candida famata), a rare human fungal pathogen often misidentified as Pichia guilliermondii (Candida guilliermondii)
    Marie Desnos-Ollivier
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA 3012, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris, France
    J Clin Microbiol 46:3237-42. 2008
    ..Sequencing of either ITS or D1/D2 regions is a good tool for differentiating the species more frequently confused with D. hansenii, keeping in mind that reliable databases should be used...
  15. pmc Antifungal susceptibility profiles of 1698 yeast reference strains revealing potential emerging human pathogens
    Marie Desnos-Ollivier
    Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Paris, France
    PLoS ONE 7:e32278. 2012
    ....
  16. pmc Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier
    Caroline Charlier
    Unité de Mycologie Moléculaire, CNRS FRE2948, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    Am J Pathol 166:421-32. 2005
    ..The rapid changes in capsule structure could contribute to inability of the host immune response to control cryptococcal infection in extrapulmonary spaces...
  17. ncbi request reprint Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis
    Guillaume Breton
    Department of Infectious and Tropical Diseases, Hopital Bichat Claude Bernard, Paris, France
    AIDS 20:119-21. 2006
    ..Partial immune reconstitution induced by HAART during disseminated histoplasmosis either related to the variety capsulatum or duboisii may be associated with immune reconstitution inflammatory syndrome...
  18. pmc Molecular identification of black-grain mycetoma agents
    Marie Desnos-Ollivier
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS FRE2849, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    J Clin Microbiol 44:3517-23. 2006
    ..Epidemiological and therapeutic studies could benefit from a precise identification of the fungi responsible for black-grain mycetoma based not only on phenotypical characteristics but also on ITS sequencing...
  19. pmc Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era
    Caroline Charlier
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA 3012, Institut Pasteur, Paris, France
    PLoS ONE 3:e1950. 2008
    ..Given this, we suggest that investigation for cryptococcosis-related lesions is merited, even in the absence of neurological abnormality, if a high fungal burden is suspected on the basis of high serum and/or CSF antigen titers...
  20. pmc Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis
    Juliette Pavie
    Service d hématologie greffe de moelle, Hopital Saint Louis, Paris, France
    J Clin Microbiol 43:4902-4. 2005
    ..Prolonged use of these new antifungal agents may increase the risk of the emergence of resistant organisms...
  21. pmc Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans
    Patrick Schwarz
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS FRE2849, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    Antimicrob Agents Chemother 51:383-5. 2007
    ..Although differences were observed depending on the technique used, antagonism was never observed. The synergistic interaction was related to the mechanism of flucytosine resistance of the isolates...
  22. pmc Major role for amphotericin B-flucytosine combination in severe cryptococcosis
    Francoise Dromer
    Institut Pasteur, Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, CNRS URA3012, Paris, France
    PLoS ONE 3:e2870. 2008
    ..We assessed here the optimal therapeutic strategies for severe cryptococcosis using the observational prospective CryptoA/D study after analyzing routine clinical care of cryptococcosis in university or tertiary care hospitals...
  23. ncbi request reprint Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients
    Romain Micol
    Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France
    J Acquir Immune Defic Syndr 45:555-9. 2007
    ..To determine the prevalence, determinants ofpositivity, and clinical utility of serum cryptococcal polysaccharide (CPS) antigen testing among HIV-infected patients in 2004 in Cambodia, an area highly endemic for cryptococcosis...
  24. ncbi request reprint Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy
    Olivier Lortholary
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, Institut Pasteur, Paris, France
    AIDS 20:2183-91. 2006
    ..Immune restoration following combination antiretroviral therapy (cART) questions the maintenance of prophylaxis among HIV-infected patients with cryptococcosis...
  25. pmc In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing
    Olivier Lortholary
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA3012, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    Antimicrob Agents Chemother 51:3378-80. 2007
    ..015 to 8 microg/ml). Ninety percent of isolates with fluconazole MICs of > or =8 microg/ml (n = 509) and 90% of those with voriconazole MICs of > or =2 microg/ml (n = 80) were inhibited by 2 and 8 microg/ml of posaconazole, respectively...
  26. pmc Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans
    Caroline Charlier
    Unité de Mycologie Moléculaire, CNRS URA3012, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
    Infect Immun 77:120-7. 2009
    ..These results provide evidence for Trojan horse crossing of the BBB by C. neoformans, together with mechanisms involving free yeasts, and overall for a role of phagocytes in fungal dissemination...
  27. pmc Comparison of microsatellite length polymorphism and multilocus sequence typing for DNA-Based typing of Candida albicans
    Dea Garcia-Hermoso
    Centre National de Référence de Mycologie et des Antifongiques, Unité de Mycologie Moléculaire, CNRS URA 3012, Institut Pasteur, Paris, France
    J Clin Microbiol 45:3958-63. 2007
    ..The two methods are similarly discriminatory and can be interchangeable depending on the objectives. MLP is less expensive and faster than MLST. However, MLST is currently more accurate and additional standardization is needed for MLP...
  28. ncbi request reprint Primary cutaneous cryptococcosis: a distinct clinical entity
    Ségolène Neuville
    Centre National de Référence des Mycoses et des Antifongiques, Unité de Mycologie Moléculaire, Institut Pasteur, 75724 Paris Cedex 15, France
    Clin Infect Dis 36:337-47. 2003
    ..neoformans serotype D. Therefore, PCC is a distinct epidemiological and clinical entity with a favorable prognosis even for immunocompromised hosts...
  29. pmc Detection of caspofungin resistance in Candida spp. by Etest
    Marie Desnos-Ollivier
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA3012, Institut Pasteur, Paris Cedex 15, France
    J Clin Microbiol 46:2389-92. 2008
    ..Good discrimination between wild-type and mutant isolates was obtained. These results suggest that the Etest is valuable for the detection of caspofungin resistance in Candida spp...
  30. ncbi request reprint [Early capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier]
    Caroline Charlier
    Unité de Mycologie Moléculaire, CNRS FRE 2849, Institut Pasteur, 28 rue du Docteur Roux, 75015 Paris, France
    Med Sci (Paris) 21:685-7. 2005
  31. pmc Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients
    Pierre Loulergue
    University Paris V, Paris, France
    Emerg Infect Dis 13:1647-52. 2007
    ..We report 3 cases of imported African histoplasmosis diagnosed in France in HIV-infected patients and a literature review on similar cases...
  32. pmc The Yak1 kinase is involved in the initiation and maintenance of hyphal growth in Candida albicans
    Sophie Goyard
    Unité Biologie et Pathogénicité Fongiques, Institut National de la Recherche Agronomique USC2019, Paris, France
    Mol Biol Cell 19:2251-66. 2008
    ....
  33. pmc Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment
    Marie Desnos-Ollivier
    Institut Pasteur, National Reference Center for Mycoses and Antifungals, Molecular Mycology Unit, Paris, France
    J Clin Microbiol 49:2304-6. 2011
    ..Nevertheless, in this study, development of echinocandin resistance in C. lusitaniae isolates was observed during caspofungin treatment. This resistance resulted from missense mutation in the echinocandin target Fks1 gene...
  34. ncbi request reprint Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus
    O Lortholary
    , , Paris, France
    J Infect Dis 183:294-302. 2001
    ..Overall, these data support the idea that inflammatory responses are crucial to the eradication of cryptococcal infections in the central nervous system...
  35. ncbi request reprint Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during AIDS-associated cryptococcosis
    O Lortholary
    Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Institut Pasteur, Paris, France
    Clin Microbiol Infect 11:296-300. 2005
    ..01). During antifungal therapy, sTNFR II levels decreased (p 0.003) in parallel with the virus load and with an increase in CD4 T-cell numbers...
  36. ncbi request reprint Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide
    G Janbon
    Unité de Mycologie Moléculaire, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex, France
    Mol Microbiol 42:453-67. 2001
    ..Analysis of the capsule structure after CAS1 deletion showed that it is required for GXM O-acetylation...
  37. pmc Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006
    E Dannaoui
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA3012, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex 15, France
    Antimicrob Agents Chemother 52:778-81. 2008
    ..A clear correlation was seen between the MICs for the two drugs...
  38. pmc Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis
    E Dannaoui
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS FRE2849, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex 15, France
    Antimicrob Agents Chemother 50:2464-70. 2006
    ..These findings suggest that the in vitro antifungal susceptibility of C. neoformans, as determined with the techniques used, is not able to predict the early clinical outcome in patients with cryptococcosis...
  39. ncbi request reprint Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France
    Olivier Lortholary
    National Reference Centre for Mycoses and Antifungals, Molecular Mycology Unit bEmerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
    AIDS 19:1043-9. 2005
    ..Immune reconstitution inflammatory syndrome (IRIS) in association with cryptococcosis has been anecdotically reported following administration of highly active antiretroviral therapy (HAART)...
  40. pmc Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras
    Vincent Peigne
    Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycologie et Antifongiques, Paris, France
    Am J Trop Med Hyg 85:934-41. 2011
    ..Histoplasmosis is a rare invasive fungal infection outside disease-endemic areas. Its prognosis improved significantly during the HAART era...
  41. ncbi request reprint Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia
    Fabrice Chretien
    Laboratoire de Neuropathologie, Faculté de médecine Paris Ouest, Hopital Raymond Poincare, Garches, Paris, France
    J Infect Dis 186:522-30. 2002
    ..Thus, our data established the relevance and interest that this experimental model has for investigation of the pathogenesis of human cryptococcal meningitis...
  42. pmc Carbon assimilation profiles as a tool for identification of zygomycetes
    Patrick Schwarz
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, CNRS URA3012, Institut Pasteur, 25, rue du Dr Roux, 75724 Paris Cedex 15, France
    J Clin Microbiol 45:1433-9. 2007
    ..In conclusion, carbon assimilation profiles allowed precise and accurate identification of most Zygomycetes to the species level...
  43. pmc Synthetic analogues of beta-1,2 oligomannosides prevent intestinal colonization by the pathogenic yeast Candida albicans
    Francoise Dromer
    Unité de Mycologie Moléculaire, Institut Pasteur, 75015 Paris, France
    Antimicrob Agents Chemother 46:3869-76. 2002
    ..As most cases of human systemic candidiasis are endogenous in origin, this first demonstration that a synthetic analogue of a yeast adhesin can prevent yeast colonization in the gut opens the possibility of new prophylactic strategies...
  44. pmc In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus
    Eric Dannaoui
    Centre National de Référence Mycologie et Antifongiques, Unité de Mycologie Moléculaire, Institut Pasteur, 75724 Paris Cedex 15, France
    Antimicrob Agents Chemother 48:970-8. 2004
    ..warrants further investigations. Animal studies are needed to evaluate the in vivo efficacies of these combinations...
  45. ncbi request reprint Influence of gender and age on course of infection and cytokine responses in mice with disseminated Cryptococcus neoformans infection
    O Lortholary
    Unité de Mycologie Moléculaire, Institut Pasteur, Paris, France
    Clin Microbiol Infect 8:31-7. 2002
    ..To study the influence of gender and age on the course of infection and the cytokine response in a murine model of disseminated cryptococcosis...
  46. ncbi request reprint Cryptococcus neoformans antibody levels in patients with AIDS
    F Dromer
    , , Paris, France
    Scand J Infect Dis 20:283-5. 1988
    ....
  47. ncbi request reprint Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12
    N Rayhane
    Unite d Immuno Allergie, Institut Pasteur, Paris, France
    J Infect Dis 180:1637-47. 1999
    ....
  48. doi request reprint Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4
    Daniel Scott-Algara
    Institut Pasteur, Unité de Régulation des Infections Rétrovirales, Paris, France
    Blood 115:3708-17. 2010
    ..Therefore, our data indicate that ICL is associated with defective surface expression of CXCR4, which may be reversed by IL-2...
  49. pmc Are two Cryptococcus neoformans strains epidemiologically linked?
    D Garcia-Hermoso
    Unite de Mycologie, Institut Pasteur, Paris, France
    J Clin Microbiol 39:1402-6. 2001
    ....
  50. ncbi request reprint Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
    C Charlier
    Universite Paris V, Service des Maladies Infectieuses et Tropicales, Hopital Necker Enfants Malades, Paris, France
    J Antimicrob Chemother 57:384-410. 2006
    ..Its prophylactic use should however be limited to selected high-risk patients to limit the risk of emergence of azole-resistant strains...